Compare HBIO & FOFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HBIO | FOFO |
|---|---|---|
| Founded | 1901 | 2017 |
| Country | United States | Hong Kong |
| Employees | N/A | 14 |
| Industry | Biotechnology: Laboratory Analytical Instruments | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.7M | 29.7M |
| IPO Year | 2000 | N/A |
| Metric | HBIO | FOFO |
|---|---|---|
| Price | $6.69 | $3.63 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $18.00 | N/A |
| AVG Volume (30 Days) | ★ 72.3K | 51.9K |
| Earning Date | 05-11-2026 | 03-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $116,176,000.00 | N/A |
| Revenue This Year | $4.77 | N/A |
| Revenue Next Year | $8.55 | N/A |
| P/E Ratio | ★ N/A | $11.09 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.28 | $2.86 |
| 52 Week High | $7.00 | $68.00 |
| Indicator | HBIO | FOFO |
|---|---|---|
| Relative Strength Index (RSI) | 70.00 | 43.14 |
| Support Level | $0.47 | $3.78 |
| Resistance Level | N/A | $5.74 |
| Average True Range (ATR) | 0.52 | 0.47 |
| MACD | 0.02 | -0.10 |
| Stochastic Oscillator | 90.85 | 17.32 |
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.
Hang Feng Technology Innovation Co Ltd is committed to providing comprehensive corporate management consulting and asset management services, tailored to address the specific needs of each client. Its goal is to empower its clients to design, implement, and achieve their unique business and investment objectives. Its business consists of two main segments: (i) corporate management consulting services and (ii) asset management services. The corporate management consulting services include Management consulting, and Regulatory compliance and governance consulting.